Teleflex
About: Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Employees: 14,500
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
99% more call options, than puts
Call options by funds: $5.07M | Put options by funds: $2.55M
50% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 3 (+1) [Q3]
33% more repeat investments, than reductions
Existing positions increased: 204 | Existing positions reduced: 153
8% more capital invested
Capital invested by funds: $10.3B [Q2] → $11.1B (+$773M) [Q3]
5% more first-time investments, than exits
New positions opened: 65 | Existing positions closed: 62
1% more funds holding
Funds holding: 515 [Q2] → 518 (+3) [Q3]
8.88% less ownership
Funds ownership: 103.79% [Q2] → 94.91% (-8.88%) [Q3]
Research analyst outlook
3 Wall Street Analysts provided 1 year price targets over the past 3 months
3 analyst ratings
Truist Securities Richard Newitter 74% 1-year accuracy 31 / 42 met price target | 13%upside $200 | Hold Maintained | 18 Dec 2024 |
Mizuho Anthony Petrone 39% 1-year accuracy 15 / 38 met price target | 41%upside $250 | Neutral Maintained | 1 Nov 2024 |
RBC Capital Shagun Singh 56% 1-year accuracy 44 / 78 met price target | 38%upside $245 | Outperform Maintained | 1 Nov 2024 |
Financial journalist opinion
Based on 4 articles about TFX published over the past 30 days
